Proactive Investors - Run By Investors For Investors

OptiBiotix SlimBiome wins award for Weight Management Ingredient of the Year

The AIM-listed firm said the award is given to the product identified by a panel of scientific, regulatory and industry experts demonstrating leading edge research and innovation in the weight management market
cholesterol
In November 2017 SlimBiome won the award for ‘Best Functional Ingredient for Health and Well Being’ at Food Matters

OptiBiotix Health plc (LON:OPTI) has announced that its weight management ingredient SlimBiome has won the award for Weight Management Ingredient of the Year at the Vitafoods European tradeshow in Geneva.

The AIM-listed firm said the award is given to the product identified by a panel of scientific, regulatory and industry experts demonstrating leading edge research and innovation in the weight management market.

READ: OptiBiotix to bring cholesterol reduction product to India with new agreement

OptiBiotix, which develops a range of compounds to tackle obesity, high cholesterol, diabetes and skin care, said the award for Weight Management Ingredient of the Year at Vitafoods is the second industry award for SlimBiome.

In November 2017 SlimBiome won the award for ‘Best Functional Ingredient for Health and Well Being’ at Food Matters.

Stephen O’Hara, CEO of OptiBiotix, said: “Having a product with a known mechanism of action, clinical and consumer studies showing its safety and effectiveness, and the support of leading international key opinion leaders, helps give confidence to consumers in their product choice.”

He added: “Hunger free dieting is now a consumer option and we hope that the increasing number of food applications containing SlimBiome will help bring the benefits of this exciting new technology to a wider international audience."

  

View full OPTI profile View Profile

OptiBiotix Health plc Timeline

Related Articles

scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
myLotus testing kit
October 31 2018
The launch at the Fertility Show in London at the start of November is the first step in a switch in focus brought about by new executive chairman Matthew Walls
cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use